Aldehyde dehydrogenase 1 is associated with recurrence-free survival but not stem cell-like properties in hepatocellular carcinoma

Hepatology Research

Volumn 42, Issue 11, 2012, Pages 1100-1111

  Suzuki, Eiichiro ^a   Chiba, Tetsuhiro ^a   Zen, Yoh ^b   Miyagi, Satoru ^a   Tada, Motohisa ^a   Kanai, Fumihiko ^a   Imazeki, Fumio ^a   Miyazaki, Masaru ^a   Iwama, Atsushi ^a   Yokosuka, Osamu ^a  

^a CHIBA UNIVERSITY   (Japan)

^b KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

Aldehyde dehydrogenase 1 A1; Cancer stem cell; Epithelial cell adhesion molecule; Hepatocellular carcinoma; Tumor initiating cell

Indexed keywords

ALDEHYDE DEHYDROGENASE; ALPHA FETOPROTEIN; EPITHELIAL CELL ADHESION MOLECULE; SHORT HAIRPIN RNA; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CANCER STEM CELL; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CELL CARCINOMA; LOSS OF FUNCTION MUTATION; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECURRENCE FREE SURVIVAL;

EID: 84868007520     PISSN: 13866346     EISSN: 1872034X     Source Type: Journal    
DOI: 10.1111/j.1872-034X.2012.01028.x     Document Type: Article

References (31)

1. Sládek NE. Human aldehyde dehydrogenases: potential pathological, pharmacological, and toxicological impact. J Biochem Mol Toxicol 2003; 17: 7-23.
2. Marchitti SA, Brocker C, Stagos D et al. Non-P450 aldehyde oxidizing enzymes: the aldehyde dehydrogenase superfamily. Expert Opin Drug Metab Toxicol 2008; 4: 697-720.
3. Armstrong L, Stojkovic M, Dimmick I et al. Phenotypic characterization of murine primitive hematopoietic progenitor cells isolated on basis of aldehyde dehydrogenase activity. Stem Cells 2004; 22: 1142-51.
4. Corti S, Locatelli F, Papadimitriou D, Donadoni C, Salani S, Del Bo R. Identification of a primitive brain-derived neural stem cell population based on aldehyde dehydrogenase activity. Stem Cells 2006; 24: 975-85.
5. Chute JP, Muramoto GG, Whitesides J et al. Inhibition of aldehyde dehydrogenase and retinoid signaling induces the expansion of human hematopoietic stem cells. Proc Natl Acad Sci U S A 2006; 103: 11707-12.
6. Reya T, Morrison SJ, Clarke MF, Weissman IL. Stem cells, cancer, and cancer stem cells. Nature 2001; 414: 105-11.
7. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A 2003; 100: 3983-8.
8. Ginestier C, Hur MH, Charafe-Jauffret E et al. ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell 2007; 1: 555-67.
9. Huang EH, Hynes MJ, Zhang T et al. Aldehyde dehydrogenase 1 is a marker for normal and malignant human colonic stem cells (SC) and tracks SC overpopulation during colon tumorigenesis. Cancer Res 2009; 69: 3382-9.
10. Deng S, Yang X, Lassus H et al. Distinct expression levels and patterns of stem cell marker, aldehyde dehydrogenase isoform 1 (ALDH1), in human epithelial cancers. PLoS ONE 2010; 5: e10277.
11. Jiang F, Qiu Q, Khanna A et al. Aldehyde dehydrogenase 1 is a tumor stem cell-associated marker in lung cancer. Mol Cancer Res 2009; 7: 330-8.
12. Tanei T, Morimoto K, Shimazu K et al. Association of breast cancer stem cells identified by aldehyde dehydrogenase 1 expression with resistance to sequential Paclitaxel and epirubicin-based chemotherapy for breast cancers. Clin Cancer Res 2009; 15: 4234-41.
13. Druesne-Pecollo N, Tehard B, Mallet Y et al. Alcohol and genetic polymorphisms: effect on risk of alcohol-related cancer. Lancet Oncol 2009; 10: 173-80.
14. Chiba T, Kita K, Zheng YW et al. Side population purified from hepatocellular carcinoma cells harbors cancer stem cell-like properties. Hepatology 2006; 44: 240-51.
15. Iwama A, Oguro H, Negishi M et al. Enhanced self-renewal of hematopoietic stem cells mediated by the polycomb gene product Bmi-1. Immunity 2004; 21: 843-51.
16. Yamashita T, Ji J, Budhu A et al. EpCAM-positive hepatocellular carcinoma cells are tumor-initiating cells with stem/progenitor cell features. Gastroenterology 2009; 136: 1012-24.
17. Schmelzer E, Zhang L, Bruce A et al. Human hepatic stem cells from fetal and postnatal donors. J Exp Med 2007; 204: 1973-87.
18. Kamiya A, Kakinuma S, Yamazaki Y et al. Enrichment and clonal culture of progenitor cells during mouse postnatal liver development in mice. Gastroenterology 2009; 137: 1114-26.
19. Ma I, Allan AL. The role of human aldehyde dehydrogenase in normal and cancer stem cells. Stem Cell Rev 2011; 7: 292-306.
20. Moreb JS, Baker HV, Chang LJ et al. ALDH isozymes downregulation affects cell growth, cell motility and gene expression in lung cancer cells. Mol Cancer 2008; 7: 87.
21. Ma S, Chan KW, Lee TK et al. Aldehyde dehydrogenase discriminates the CD133 liver cancer stem cell populations. Mol Cancer Res 2008; 6: 1146-53.
22. Chiba T, Miyagi S, Saraya A et al. The polycomb gene product BMI1 contributes to the maintenance of tumorinitiating side population cells in hepatocellular carcinoma. Cancer Res 2008; 68: 7742-9.
23. Chiba T, Suzuki E, Negishi M et al. 3-Deazaneplanocin A is a promising therapeutic agent for the eradication of tumorinitiating hepatocellular carcinoma cells. Int J Cancer 2012; 30: 2557-67.
24. Levi BP, Yilmaz OH, Duester G et al. Aldehyde dehydrogenase 1a1 is dispensable for stem cell function in the mouse hematopoietic and nervous systems. Blood 2009; 113: 1670-80.
25. Resetkova E, Reis-Filho JS, Jain RK et al. Prognostic impact of ALDH1 in breast cancer: a story of stem cells and tumor microenvironment. Breast Cancer Res Treat 2010; 123: 97-108.
26. Chang B, Liu G, Xue F et al. ALDH1 expression correlates with favorable prognosis in ovarian cancers. Mod Pathol 2009; 22: 817-23.
27. Kahlert C, Bergmann F, Beck J et al. Low expression of aldehyde dehydrogenase 1A1 (ALDH1A1) is a prognostic marker for poor survival in pancreatic cancer. BMC Cancer 2011; 11: 275.
28. Saitoh S, Ikeda K, Koida I et al. Serum des-gammacarboxyprothrombin concentration determined by the avidin-biotin complex method in small hepatocellular carcinomas. Cancer 1994; 74: 2918-23.
29. Lee JS, Heo J, Libbrecht L et al. A novel prognostic subtype of human hepatocellular carcinoma derived from hepatic progenitor cells. Nat Med 2006; 12: 410-6.
30. Yamashita T, Forgues M, Wang W et al. EpCAM and alphafetoprotein expression defines novel prognostic subtypes of hepatocellular carcinoma. Cancer Res 2008; 68: 1451-61.
31. Dollé L, Best J, Empsen C et al. Successful isolation of liver progenitor cells by aldehyde dehydrogenase activity in naïve mice. Hepatology 2012; 55: 540-52.